Market Overview:
Septic arthritis is a serious infection that affects the joints. It can occur in any joint, but it most commonly affects the knee. Septic arthritis is a medical emergency and requires prompt treatment. The global septic arthritis treatment market is expected to grow at a CAGR of 5.5% during the forecast period 2018-2030.
Product Definition:
Septic arthritis is an infection in the joint fluid. Treatment includes antibiotics and surgery. Septic arthritis can cause permanent damage to the joint if not treated quickly.
Diagnosis:
Diagnosis is the process of determining whether a medical condition exists or not. It's used in the treatment and management of several diseases. The factors that propel growth include increasing prevalence of arthritis, growing geriatric population base, rising healthcare awareness among people and technological advancements such as introduction of portable X-ray devices & digitalization in hospitals & diagnostic centers.
Global Arthritis Diagnosis Market by Product (X-ray machines, MRI machines), by Region (North America [U.
Treatment:
Treatment and it's usage in Septic Arthritis is a book by Dr. Robert S. Mendelsohn, published in 2005 by Mosby Inc., which provides information on the treatment of arthritis with septicemia. The book is dedicated to all those who have suffered from rheumatoid arthritis or osteoarthritis and are looking for an alternative treatment option as well as those who are concerned about their family members suffering from these diseases.
Application Insights:
The market is segmented by application into orthopedic hospitals, clinics, diagnostic centers, and hospitals. The clinics segment dominated the market in 2017 owing to factors such as increasing geriatric population and rising cases of sports injuries. According to a study published by the WHO in 2018, it was estimated that around 1 billion people aged 60 years or above were registered globally. Moreover, according to data published by International Osteoporosis Foundation (IOF), around 8 million hip fractures have been reported globally since 1990s which resulted in more than half a million deaths every year since then. These factors are expected to increase demand for septic arthritis treatment over the forecast period thus driving the growth of this segment during future years.
Regional Analysis:
North America dominated the global Septic Arthritis Treatment Market in 2017. This can be attributed to the presence of a large number of market players, high awareness levels coupled with relatively higher healthcare expenditure and availability of advanced treatment options for patients suffering from septic arthritis. In addition, increasing prevalence of orthopedic conditions is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population and improving economic status in emerging countries such as China & India which are further fueling product demand due to growing medical tourism industry.
Growth Factors:
- Increasing incidence of septic arthritis
- Growing awareness about septic arthritis and its treatment options
- Rising demand for minimally invasive procedures for septic arthritis treatment
- Technological advancements in septic arthritis treatment procedures
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Septic Arthritis Treatment Market Research Report
By Type
Diagnosis, Treatment
By Application
Orthopedic Hospitals, Clinics, Diagnostic Centers, Hospitals
By Companies
Lupin Pharmaceuticals (US), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc (US), Amgen Inc (US), Bristol-Myers Squibb Company (US), Johnson & Johnson (US), Pfizer (US)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Septic Arthritis Treatment Market Report Segments:
The global Septic Arthritis Treatment market is segmented on the basis of:
Types
Diagnosis, Treatment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Orthopedic Hospitals, Clinics, Diagnostic Centers, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lupin Pharmaceuticals (US)
- F. Hoffmann-La Roche Ltd (Swtizerland)
- AbbVie Inc (US)
- Amgen Inc (US)
- Bristol-Myers Squibb Company (US)
- Johnson & Johnson (US)
- Pfizer (US)
Highlights of The Septic Arthritis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnosis
- Treatment
- By Application:
- Orthopedic Hospitals
- Clinics
- Diagnostic Centers
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Septic Arthritis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Septic arthritis is a type of arthritis that is caused by infection in the joint. Treatment typically includes antibiotics and pain relief. Surgery may also be necessary to remove the infection or to replace the damaged joint.
Some of the major players in the septic arthritis treatment market are Lupin Pharmaceuticals (US), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc (US), Amgen Inc (US), Bristol-Myers Squibb Company (US), Johnson & Johnson (US), Pfizer (US).
The septic arthritis treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Septic Arthritis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Septic Arthritis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Septic Arthritis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Septic Arthritis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Septic Arthritis Treatment Market Size & Forecast, 2018-2028
4.5.1 Septic Arthritis Treatment Market Size and Y-o-Y Growth
4.5.2 Septic Arthritis Treatment Market Absolute $ Opportunity
Chapter 5 Global Septic Arthritis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Septic Arthritis Treatment Market Size Forecast by Type
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Septic Arthritis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Septic Arthritis Treatment Market Size Forecast by Applications
6.2.1 Orthopedic Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Centers
6.2.4 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Septic Arthritis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Septic Arthritis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Septic Arthritis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Septic Arthritis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Septic Arthritis Treatment Market Size Forecast by Type
9.6.1 Diagnosis
9.6.2 Treatment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Septic Arthritis Treatment Market Size Forecast by Applications
9.10.1 Orthopedic Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Centers
9.10.4 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Septic Arthritis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Septic Arthritis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Septic Arthritis Treatment Market Size Forecast by Type
10.6.1 Diagnosis
10.6.2 Treatment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Septic Arthritis Treatment Market Size Forecast by Applications
10.10.1 Orthopedic Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Centers
10.10.4 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Septic Arthritis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Septic Arthritis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Septic Arthritis Treatment Market Size Forecast by Type
11.6.1 Diagnosis
11.6.2 Treatment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Septic Arthritis Treatment Market Size Forecast by Applications
11.10.1 Orthopedic Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Centers
11.10.4 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Septic Arthritis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Septic Arthritis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Septic Arthritis Treatment Market Size Forecast by Type
12.6.1 Diagnosis
12.6.2 Treatment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Septic Arthritis Treatment Market Size Forecast by Applications
12.10.1 Orthopedic Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Centers
12.10.4 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Septic Arthritis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Septic Arthritis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Septic Arthritis Treatment Market Size Forecast by Type
13.6.1 Diagnosis
13.6.2 Treatment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Septic Arthritis Treatment Market Size Forecast by Applications
13.10.1 Orthopedic Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Centers
13.10.4 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Septic Arthritis Treatment Market: Competitive Dashboard
14.2 Global Septic Arthritis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lupin Pharmaceuticals (US)
14.3.2 F. Hoffmann-La Roche Ltd (Swtizerland)
14.3.3 AbbVie Inc (US)
14.3.4 Amgen Inc (US)
14.3.5 Bristol-Myers Squibb Company (US)
14.3.6 Johnson & Johnson (US)
14.3.7 Pfizer (US)
